Comparative Study Between the AirGoTM System and Standard Tests in the Assessment of the Respiratory Function

NCT ID: NCT03368612

Last Updated: 2017-12-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-09-22

Study Completion Date

2019-09-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims at evaluating the AirGoTM system's performance, as compared to standard pulmonary function tests.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary endpoint:

• To test the AirGoTM system's respiratory rate recording accuracy at rest and during physical exercise, as compared to standard tests.

Secondary endpoints:

* To test the accuracy of the AirGoTM system's derived respiratory parameters (tidal volume, minute ventilation, Tiffeneau-Pinelli index, FEV1 and VO2max) at rest and during physical exercise, as compared to standard tests.
* To test comfort and subjects' compliance with the AirGoTM system during long term recording (24 hours).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiration Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electronic evaluation system

spirometry, plethysmography, cardiopulmonary exercise test

Intervention Type OTHER

Electronic evaluation system

AirGo recording

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

AirGoTM System

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Non-smoker healthy volunteers,
* Able to perform a routine respiratory function test (spirometry and cardiopulmonary exercise testing),
* aged between 18 and 75 years,
* who signed a written informed consent.

Exclusion Criteria

* Present cardiac comorbidities (eg. coronary artery disease, heart failure, arrhythmias);
* History of coronary artery disease or heart failure;
* Respiratory comorbidities (eg. asthma, chronic obstructive disease, sleep apnoea, lung interstitial disease);
* Pregnancy;
* Former smoker of \>5 p/y;
* Severe trauma or major surgery in the last year;
* Chest pain;
* Obesity (BMI \>30).
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ospedale Santa Croce-Carle Cuneo

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Andrea Antonelli

Principal Investigator, MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

A.O. S. Croce E Carle Di Cuneo

Cuneo, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

ANDREA ANTONELLI, MD

Role: CONTACT

Phone: +39017161

Email: [email protected]

ALESSIA STANZI, MD

Role: CONTACT

Phone: +39017161

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

FRANCESCO GIURLANDA

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A.O. S. Croce e Carle di Cuneo

Identifier Type: -

Identifier Source: org_study_id